Skip to main content
. 2017 Dec 29;11:1558–1567. doi: 10.2174/1874325001711011558

Fig. (7).

Fig. (7)

The average starting age for patients in the study was 12.4 years. After an average follow-up time of 30.4 months (see red frame), the patients are more mature, their growth rate is decreased and the risk of further progression is significantly reduced.